NasdaqGS - Nasdaq Real Time Price USD

Xeris Biopharma Holdings, Inc. (XERS)

Compare
3.2650 +0.0450 (+1.40%)
As of 11:24 AM EDT. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
322,602.0000
344,522.0000
304,361.0000
159,151.0000
Total Liabilities Net Minority Interest
329,384.0000
299,335.0000
209,130.0000
125,390.0000
Total Equity Gross Minority Interest
-6,782.0000
45,187.0000
95,231.0000
33,761.0000
Total Capitalization
184,150.0000
232,262.0000
183,298.0000
120,782.0000
Common Stock Equity
-6,782.0000
45,187.0000
95,231.0000
33,761.0000
Capital Lease Obligations
38,259.0000
10,982.0000
--
--
Net Tangible Assets
-139,405.0000
-98,279.0000
-59,078.0000
33,761.0000
Working Capital
61,071.0000
113,197.0000
63,556.0000
124,005.0000
Invested Capital
184,150.0000
232,262.0000
183,298.0000
120,782.0000
Tangible Book Value
-139,405.0000
-98,279.0000
-59,078.0000
33,761.0000
Total Debt
229,191.0000
198,057.0000
88,067.0000
87,021.0000
Net Debt
123,483.0000
65,109.0000
20,796.0000
49,423.0000
Share Issued
138,130.7150
136,273.0900
124,873.3160
59,611.2020
Ordinary Shares Number
138,130.7150
136,273.0900
124,873.3160
59,611.2020
12/31/2020 - 6/21/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers